Noticias 2020

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetesHeller S, Battelino, Bailey T, Pieber T, Pieber T et aldoi.org/10.1111/dom.14987

read more

Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022Frankel A, Whaba M,  Ashworth V, Bedi R, Berrington et alhttps://doi.org/10.1111/dme.15027

read more

Reunión Clínica Marzo 2023

Reuniones Clínicas AnterioresSábado 11 de Marzo, 2023 VÍA STREAMING T E M A R I O 10:00 – 10:45 horas CASO 1 “DIABETES DE INICIO ABRUPTO CON CAD RECURRENTE ASOCIADO A USO DE PEMBROLIZUMAB EN MELANOMA METASTASICO” Presenta:  Dra. Karina Elgueta Rodríguez, Medicina...

read more

Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guidelineEystein S Husebye, Frederik Castinetti, et al. Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. https://doi.org/10.1530/EJE-22-0689

read more

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statementMargaret C S Boguszewski, Cesar L Boguszewski , et al. Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52. https://doi.org/10.1530/EJE-21-1186

read more

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International WorkshopJohn P Bilezikian 1, Aliya A Khan, et al. J Bone Miner Res. 2022 Nov;37(11):2293-2314. https://doi.org/10.1002/jbmr.4677

read more

Genetics of Cushing's disease: from the lab to clinical practiceMarily Theodoropoulou , Martin Reincke Pituitary. 2022 Oct;25(5):689-692. https://doi.org/10.1007/s11102-022-01253-9

read more

Tumor-induced Osteomalacia: A Comprehensive ReviewSalvatore Minisola , Seiji Fukumoto, et al.  Endocr Rev. 2023 Mar 4;44(2):323-353.  https://doi.org/10.1210/endrev/bnac026

read more